The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...
U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback